Quadricuspid Aortic Valve: The Diagnosis Hiding in Your Short-Axis View

Key Takeaways

• Quadricuspid valve shows X‑shaped cusps on short‑axis view
• Mislabelled as bicuspid, leading to missed regurgitation progression
• Short‑axis measurement distinguishes four cusps from three
• Accurate diagnosis enables timely valve repair or replacement

Pulse Analysis

Quadricuspid aortic valves (QAV) represent less than 0.04% of all congenital heart defects, yet their clinical relevance is disproportionate to their rarity. The extra cusp alters valve dynamics, often precipitating moderate to severe aortic regurgitation earlier than typical tricuspid anatomy. Because QAVs lack a distinct textbook description in many training programs, they slip through routine echocardiographic screens, especially when sonographers default to the more familiar bicuspid classification. Recognizing the prevalence gap underscores the need for heightened awareness among cardiologists and imaging specialists.

The short‑axis (parasternal) view is the diagnostic linchpin for QAV detection. When the ultrasound probe aligns perpendicular to the aortic root, the four cusps create a characteristic X‑shaped silhouette, contrasting with the Y‑shaped pattern of a bicuspid valve or the triangular arrangement of a tricuspid valve. Precise measurement of cusp thickness, commissural spacing, and coaptation height in this plane allows clinicians to differentiate true quadricuspid morphology from fused bicuspid variants. Incorporating color Doppler to assess regurgitant jets further validates the diagnosis and quantifies severity, guiding therapeutic thresholds.

From a management perspective, early identification of QAV changes the therapeutic trajectory. Patients with significant regurgitation may benefit from earlier surgical referral for valve repair or replacement, avoiding the progressive ventricular dilation that accompanies delayed treatment. Moreover, accurate labeling informs family screening, as some QAV cases cluster in hereditary patterns. Ongoing research into minimally invasive transcatheter options for atypical valve anatomies promises to expand treatment choices, making precise echocardiographic classification more critical than ever.